An innovative AI tool for pediatric cancer relapse prediction is paving the way for transformative advancements in the fight against brain tumors.Developed by researchers from Mass General Brigham, this cutting-edge technology leverages AI medical imaging to meticulously analyze brain scans over time, greatly enhancing the capacity to forecast recurrence risks for pediatric glioma patients.